-
3 Oncology Generics, Branded Generics and Biologics Platform Stocks With a Strong Future Roadmap: Natco Pharma, Emcure Pharmaceuticals and Shilpa Medicare
- October 21, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
No Comments
Specialty Generics and Oncology Stocks with a strong future roadmap: Natco Pharma, Emcure Pharmaceuticals and Shilpa Medicare. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.
-
3 Ophthalmic Brands, Cancer Generics and Pharma Excipients Stocks With a Strong Future Roadmap: Ajanta Pharma, Natco Pharma and Sudeep Pharma
- October 21, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
Oncology and Excipient Pharma Stocks with a strong future roadmap: Ajanta Pharma, Natco Pharma and Sudeep Pharma. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.